DMAE (Dimethylaminoethanol) vs Tongkat Ali (Eurycoma longifolia)

Side-by-side comparison of mechanisms, dosing, interactions, and stacking potential.

✅ Stacking Partners — These compounds are commonly used together and may have synergistic effects.
DMAE (Dimethylaminoethanol)Tongkat Ali (Eurycoma longifolia)
CategoryNootropicsAdaptogens
Standard Dose150-400 mg/day (as DMAE bitartrate, typically 37% DMAE)200-400mg daily (standardized to 2% eurycomanone or 22-40% bioactive content)
TimingMorning. With or without food.Morning with or without food. Can split AM/PM.
Cycle DurationOngoing; no strict cycling requiredCycle 8 weeks on, 2 weeks off (or 5 days on, 2 off)
Evidence Levelanimal_plus_anecdotalmoderate_human

Mechanism

Structural analog of choline that crosses the BBB more readily than choline itself. Paradoxically increases choline availability not by serving as a direct precursor to acetylcholine, but by inhibiting choline metabolism in peripheral tissues, thereby increasing circulating choline available for brain uptake. Also acts as a free radical scavenger and membrane stabilizer. Reduces lipofuscin accumulation in neuronal cells, an age pigment associated with cellular aging.

Standard Dosing

150-400 mg/day (as DMAE bitartrate, typically 37% DMAE)

Timing

Morning. With or without food.

Cycle Duration

Ongoing; no strict cycling required

Side Effects

  • Headache
  • Insomnia
  • Muscle tension
  • Overstimulation
  • GI discomfort
  • Vivid dreams

Contraindications

  • Pregnancy (potential teratogenic effects — inhibits choline incorporation into phospholipids critical for fetal neural development)
  • Bipolar disorder (may worsen depressive phase)
  • Epilepsy (may lower seizure threshold)

Best Stacking Partners

RacetamsPhosphatidylserineOmega-3 (DHA)

Mechanism

Tongkat Ali contains quassinoids (eurycomanone, eurycomanol) and bioactive peptides (eurypeptides). Primary mechanisms: reduces SHBG binding, freeing testosterone; inhibits aromatase (CYP19A1), reducing estrogen conversion; modulates the HPA axis reducing cortisol; stimulates Leydig cell steroidogenesis via cAMP pathway activation; and may inhibit phosphodiesterase (PDE) enzymes. The net effect is increased free testosterone, improved testosterone:cortisol ratio, and enhanced libido via dopaminergic and NO-mediated pathways in erectile tissue.

Standard Dosing

200-400mg daily (standardized to 2% eurycomanone or 22-40% bioactive content)

Timing

Morning with or without food. Can split AM/PM.

Cycle Duration

Cycle 8 weeks on, 2 weeks off (or 5 days on, 2 off)

Side Effects

  • Insomnia
  • Restlessness
  • Increased aggression (rare)
  • Mild GI discomfort
  • Elevated heart rate (rare)

Contraindications

  • Hormone-sensitive cancers (prostate, breast)
  • Pregnancy/lactation
  • Children
  • Severe liver disease
  • Hormone-sensitive cancers
  • Concurrent TRT (redundant mechanism)

Best Stacking Partners

Fadogia AgrestisAshwagandha (KSM-66)BoronZincDIM

Not sure which is right for you?

Take our free assessment to get personalized recommendations based on your health goals, current stack, and biomarkers.

Get Your Free Protocol →or take the assessment →